PWMG
NVO

Prestige Wealth Management Group’s Novo Nordisk NVO Stock Holding History

Prestige Wealth Management Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.62K Hold
159
– – ﹤0.01% 489
2026
Q1 		$6.04K Sell
159
-220
-58% -$10.4K ﹤0.01% 517
2025
Q4 		$19.3K Hold
379
– – ﹤0.01% 351
2025
Q3 		$21K Hold
379
– – ﹤0.01% 358
2025
Q2 		$26.2K Hold
379
– – 0.01% 324
2025
Q1 		$26.8K Hold
379
– – 0.01% 315
2024
Q4 		$32.6K Hold
379
– – 0.01% 306
2024
Q3 		$45.1K Hold
379
– – 0.01% 257
2024
Q2 		$54.1K Hold
379
– – 0.01% 218
2024
Q1 		$49K Hold
379
– – 0.01% 256
2023
Q4 		$39.2K Sell
379
-15
-4% -$1.48K 0.01% 266
2023
Q3 		$35.8K Hold
394
– – 0.01% 271
2023
Q2 		$31.9K Hold
394
– – 0.01% 309
2023
Q1 		$31.6K Sell
394
-126
-24% -$8.94K 0.01% 277
2022
Q4 		$35.2K Buy
520
+52
+11% +$3.05K 0.01% 287
2022
Q3 		$23K Sell
468
-16
-3% -$857 0.01% 296
2022
Q2 		$27K Hold
484
– – 0.01% 292
2022
Q1 		$27K Hold
484
– – 0.01% 301
2021
Q4 		$27K Hold
484
– – 0.01% 330
2021
Q3 		$23K Hold
484
– – 0.01% 352
2021
Q2 		$20K Hold
484
– – 0.01% 363
2021
Q1 		$16K Sell
484
-78
-14% -$2.78K ﹤0.01% 388
2020
Q4 		$20K Sell
562
-22
-4% -$760 0.01% 355
2020
Q3 		$20K Hold
584
– – 0.01% 350
2020
Q2 		$19K Sell
584
-10
-2% -$319 0.01% 343
2020
Q1 		$18K Buy
594
+584
+5,840% +$17.4K 0.01% 296
2019
Q4 		$0 Hold
10
– – ﹤0.01% 639
2019
Q3 		$0 Buy
+10
New +$253 ﹤0.01% 625
2019
Q2 		– Sell
-766
Closed -$20K – 503
2019
Q1 		$20K Sell
766
-142
-16% -$3.49K 0.01% 280
2018
Q4 		$21K Buy
+908
New +$20.2K 0.02% 299

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Prestige Wealth Management Group's NVO Position: Q2 2026 in Review

Prestige Wealth Management Group held its Novo Nordisk (NVO) position steady in Q2 2026 at 159 shares worth $7.62K. The position accounts for ﹤0.01% of the portfolio, ranked #489.

Prestige Wealth Management Group first reported a position in NVO in Q4 2018 and has held it in 30 quarters since. The position peaked at $54.1K in Q2 2024. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Prestige Wealth Management Group held 159 shares of Novo Nordisk worth $7.62K as of Q2 2026.
  • Prestige Wealth Management Group left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up ﹤0.01% of Prestige Wealth Management Group's portfolio in Q2 2026, its #489 holding.
  • Prestige Wealth Management Group first reported a position in Novo Nordisk in Q4 2018 and has held it in 30 quarters since.
  • Prestige Wealth Management Group's Novo Nordisk position peaked at $54.1K in Q2 2024.
  • 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.